Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Larumbe

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Revista De Medicina De La Universidad De Navarra|January 1, 1997
[Cerebral SPECT and neuropsychological function in Alzheimer's disease]J Arbizu, R Larumbe, L Rubio, et al.
Revista Espanola De Salud Publica|June 13, 2001
[Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease]R Larumbe Ilundáin, J V Ferrer Valls, J J Viñes Rueda, et al.
Anales Del Sistema Sanitario De Navarra|July 16, 2003
[Prevalence of CYPD6 mutations in sporadic Parkinson's disease: case-control study]D Guerrero, M García-Delgado, R Larumbe, et al.
Neurology|July 1, 1994
Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementiaO L Lopez, M R Larumbe, J T Becker, et al.
Neurologia (Barcelona, Spain)|June 1, 1997
[Standardization of the Alzheimer's Disease Assessment Scale in a Spanish population]L F Pascual, P Saz, R Larumbe, et al.
Neuroepidemiology|January 1, 1995
Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, SpainJ M Manubens, J M Martínez-Lage, F Lacruz, et al.
Neurologia (Barcelona, Spain)|June 3, 1998
[Variation of Mini-Mental-State examination scores due to age and educational level. Normalized data in the population over 70 years of age in Pamplona]J M Manubens, P Martínez-Lage, J M Martínex-Lage, et al.
Journal of Neurology|June 14, 2019
Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findingsM E Erro, M V Zelaya, M Mendioroz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Revista De Medicina De La Universidad De Navarra|January 1, 1997
[Cerebral SPECT and neuropsychological function in Alzheimer's disease]J Arbizu, R Larumbe, L Rubio, et al.
Revista Espanola De Salud Publica|June 13, 2001
[Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease]R Larumbe Ilundáin, J V Ferrer Valls, J J Viñes Rueda, et al.
Anales Del Sistema Sanitario De Navarra|July 16, 2003
[Prevalence of CYPD6 mutations in sporadic Parkinson's disease: case-control study]D Guerrero, M García-Delgado, R Larumbe, et al.
Neurology|July 1, 1994
Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementiaO L Lopez, M R Larumbe, J T Becker, et al.
Neurologia (Barcelona, Spain)|June 1, 1997
[Standardization of the Alzheimer's Disease Assessment Scale in a Spanish population]L F Pascual, P Saz, R Larumbe, et al.
Neuroepidemiology|January 1, 1995
Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, SpainJ M Manubens, J M Martínez-Lage, F Lacruz, et al.
Neurologia (Barcelona, Spain)|June 3, 1998
[Variation of Mini-Mental-State examination scores due to age and educational level. Normalized data in the population over 70 years of age in Pamplona]J M Manubens, P Martínez-Lage, J M Martínex-Lage, et al.
Journal of Neurology|June 14, 2019
Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findingsM E Erro, M V Zelaya, M Mendioroz, et al.
Pageof 2